azathioprine has been researched along with Granulomatosis, Orofacial in 2 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Granulomatosis, Orofacial: A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. Among experts there is disagreement on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inaty, H | 1 |
| Arabelovic, S | 1 |
| Mentzer, A | 1 |
| Goel, R | 1 |
| Elliott, T | 1 |
| Campbell, H | 1 |
| Hullah, E | 1 |
| Patel, P | 1 |
| Challacombe, S | 1 |
| Escudier, M | 1 |
| Sanderson, JD | 1 |
2 other studies available for azathioprine and Granulomatosis, Orofacial
| Article | Year |
|---|---|
α1-Antitrypsin deficiency in a patient diagnosed with granulomatosis with polyangiitis.
Topics: Adult; alpha 1-Antitrypsin; Azathioprine; Biopsy; Diagnosis, Differential; Female; Glucocorticoids; | 2013 |
Azathioprine is effective for oral involvement in Crohn's disease but not for orofacial granulomatosis alone.
Topics: Adult; Azathioprine; Crohn Disease; Female; Granulomatosis, Orofacial; Humans; Intestinal Diseases; | 2016 |